Lataa...
Initial Testing (Stage 1) of the Phosphatidylinositol 3’ Kinase Inhibitor, SAR245408 (XL147) by the Pediatric Preclinical Testing Program
BACKGROUND: Activation of the PI3 kinase pathway occurs frequently in many adult cancers and is implicated in tumor cell proliferation, survival, and resistance to chemotherapy and radiotherapy. However, less is known regarding the relevance of this pathway in pediatric cancers. Here we have evaluat...
Tallennettuna:
| Julkaisussa: | Pediatr Blood Cancer |
|---|---|
| Päätekijät: | , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4684943/ https://ncbi.nlm.nih.gov/pubmed/23002019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24301 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|